Electromed Story

<div class='circular--portrait' style='background:#689CFD;color: #ffffff;font-size:4em;'>EL</div>
ELMD -- USA Stock  

USD 10.33  0.08  0.77%

As many baby boomers are indifferent towards healthcare space, it makes sense to digest Electromed against current market trends. As expected, Electromed is starting to reaffirm its true potential as shareholders are becoming more and more confident in the future outlook. The returns on investing in Electromed and the market returns of the last few months appear uncorrelated. Unsteady basic indicators of the firm may also indicate signs of longer-term losses for Electromed shareholders. Electromed is scheduled to announce its earnings today. The next earnings report is expected on the 10th of November 2020.
Published over a month ago
View all stories for Electromed | View All Stories
Is Electromed (NYSEMKT:ELMD) outlook still optimistic?
Electromed's average rating is Buy from 1 analysts. Do analysts base this consensus on technical analyses? We know that typical technical analysis utilizes price momentum, patterns, and trends looking at historical prices. It aims to identify signals based on Electromed market sentiment investors' perception of the future value of Electromed. Let us look at a few aspects of Electromed technical analysis. The company has Profit Margin (PM) of 11.5 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 15.97 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.16.
Using predictive technical analysis, we will analyze different prices and returns patterns and diagnose historical swings to determine the real value of Electromed. In general, we focus on analyzing Electromed stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Electromed's daily price indicators and compare them against related drivers such as momentum indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Electromed's intrinsic value. In addition to deriving basic predictive indicators for Electromed, we also check how macroeconomic factors affect Electromed price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.

How does Electromed Stands against Peers?

Analyzing Electromed competition or peers my help you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Try to analyze the advantages of investing in traded instruments related to Electromed across multiple sectors and thematic ideas. A good competitive analysis can cover a lot of different areas. But what areas to choose depends on who you are. The more exhaustive you are in your analysis, the more effective your competitive analysis will be.
Check out Electromed Competition Details

How Electromed utilizes its cash?

To perform a cash flow analysis of Electromed, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Electromed is receiving and how much cash it distributes out in a given period. The Electromed cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Electromed Net Cash Flow from Operations is projected to increase significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at 4.2 Million

Closer look at Electromed Semi Deviation

Electromed has current Semi Deviation of 3.77. Semi-deviation provides a good measure of downside risk for a equity or a portfolio. It is similar to standard deviation, but it only looks at periods where the returns are less than the target or average level.

Semi-deviation is the square root of semi-variance. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.

Semi Deviation 
=  
SQRT(SV) 
 = 
3.77
SQRT = Square root notation
SV =   Electromed semi variance of returns over selected period
Let's now compare Electromed Semi Deviation to its closest peers:
ELMD
ESTA
ESMC
EDAP
ELMD3.77
ESTA3.65
ESMC9.07
EDAP2.49

Will Electromed growth be reliable after the surge?

The variance is down to 14.77 as of today. Electromed shows above-average downside volatility for the selected time horizon. We advise investors to inspect Electromed further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Electromed future alpha.

Our Takeaway on Electromed Investment

Although many of the other players under the medical devices industry are still a bit expensive, Electromed may offer a potential longer-term growth to shareholders. To summarize, as of the 25th of August 2020, our research shows that Electromed is a rather not too volatile investment opportunity with a close to average probability of distress in the next two years. From a slightly different view, the entity currently appears to be undervalued. However, our up-to-date 30 days buy-hold-sell recommendation on the firm is Strong Sell.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Electromed. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com